Fri, September 22, 2023
Thu, September 21, 2023
Wed, September 20, 2023
Tue, September 19, 2023
Mon, September 18, 2023
Fri, September 15, 2023
Thu, September 14, 2023

Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $43 on, Sep 19th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-43-on-sep-19th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $43 on, Sep 19th, 2023.

Raghuram has made no other calls on ACRS in the last 4 months.



There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Alex Thompson of "Stifel" Maintained at Strong Buy with Increased Target to $20 on, Thursday, September 14th, 2023

Publication Contributing Sources